Search results

1. Professor James Brenton

   ... in resistance has been to develop novel phase II clinical trials with sequential collection and profiling of ovarian cancer tissues ...

2. Dr Massimiliano di Pietro

   ... recent multi-centre studies led by our group (TIME and ACE-B trials) have demonstrated that it is possible to increase diagnostic accuracy ...

3. Dr Michael Gattens

   ... am principal investigator for a number of national leukaemia trials, and coinvestigator for trials of new haemophilia factor concentrates in paediatric haemophilia ...

4. Dr Phil Jewsbury

   ... pre-clinical candidate drugs to proof-of-concept Phase 2 trials. Currently a Senior Project Director in AstraZeneca Oncology ...

5. Dr Richard Baird

   Early phase clinical trials, including expertise in: - first-in-human studies & drug combination trials - new small molecule & antibody therapeutics - development of ... cancer therapeutics. Investigator-initiated clinical trials funded by:  - Cancer Research UK  - EU HORIZON 2020 - AntiCancer ...

6. Professor Richard Gilbertson

   ... Program and founding Director of the Molecular Clinical Trials Core before being appointed as the Comprehensive Cancer Center Director, ...

7. Mr Richard Skells

   ... studies coordinated by CCTU and Cambridge Cancer Trials Centre. ...

8. Professor Robert Rintoul

   ... at Royal Papworth Hospital and Director of the Papworth Trials Unit Collaboration. He is co-lead of the CRUK Cambridge Centre Thoracic ... Rintoul’s research is focused around clinical trials, translational research and tissue banking in malignant mesothelioma and ...

9. Dr Robert Thomas

   ... completed and published a number of national research trials including; an evaluation of the impact of exercise in relation to ...

10. Dr Tim Mitchell

    ... CRT Pioneer Fund. This programme will start Phase 1 clinical trials at the Royal Marsden Hospital in June 2016. SKIL® (Sareum Kinase ...

11. Dr Fengtong Ji

    I am concentrating on promoting developmental mechanics and microrobotic engineering, aiming at developing interdisciplinary paradigms to investigate the mechanical and physical mechanisms governing the embryonic development and morphogenetic...

12. Dr Rafael Romero Garcia

    Neurosurgical management of brain tumours has entered a new paradigm where resection is extended into the peri-tumoural margin to minimise ...

13. Dr Simon Pacey

    As a Medical Oncologist trained in early drug development, my research interests are: Early phase clinical trials (phase I/II) and Urological malignancy (prostate cancers). My projects are centered around the transition of new drugs into humans and...

14. Dr Andrew Gee

    ... to cancer research is our work on ultrasound-guided radiotherapy and two- and three-dimensional elastography. ...

15. Dr Richard Benson

    Interests based around improving radiotherapy and chemoradiotherapy in head and neck and urological cancers, develpoing technical radiotherapy and evaluating treatment related toxicity. ...

16. Dr Christopher Jones

    ... adenocarcinoma. I am also interested in the study of radiotherapy-related genomic evolution. ...

17. Professor Charlotte Coles

    ... III randomised trial (RCT) investigating intensity modulated radiotherapy (IMRT) and partial breast radiotherapy in patients at low risk of recurrence – in follow up: 2018 ...

18. Ms Ceilidh Welsh

    ... toxicity data, from nearly 3000 patients recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...

19. Professor David Neal

    ... Principal Investigator on large clinical trial of surgery, radiotherapy and monitoring in early prostate cancer (NHS R&D funded - £36M). ...

20. Dr David Noble

    ... anatomy of head and neck cancer patients undergoing curative radiotherapy. This model will permit calculation of delivered radiation dose ... in the move towards increasingly adaptive and individualised radiotherapy. ...

21. Dr Francesca M. Cozzi

    ... in concert with genetic analyses to inform surgical and radiotherapy planning.  ...

22. Dr Gill Barnett

    ... the wide variation between patients in the severity of late radiotherapy toxicity. ...

23. Dr Henno Martin

    ... free DNA to discover markers of response and toxicity in radiotherapy for prostate and other cancers. ...

24. Dr Michael Boemo

    ... are pulsed into replicating DNA, they are incorporated into newly copied DNA by replication forks leaving a "footprint" of fork movement. ...

25. Dr John Lizhe Zhuang

    ... Barrett's oesophagus (BO). OAC is a lethal cancer often diagnosed at an advanced stage, and its incidence is increasing in Western ...

26. Dr Sarah Jefferies

    ... analysis and pseudo progression in patients treated for glioblastoma (T Booth, K Brindle; CRI) Collaborator in Gala 5 Study (CRUK grant ...

27. Miss Magda Gerigk

    ... working on developing microfluidic devices to mimic glioblastoma niches. ...

28. Dr Myriam Ouberai

    I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to...

29. Mr Richard Mair

    ... interested in understanding the heterogeneity present within glioblastoma and how this can be understood through the development of novel ...

30. Miss Ye Liu

    My PhD project will be focused on glioblastoma, the most severe and deadly form of brain cancer; and the aim is ... space in order to measure migration/invasion abilities of glioblastoma cells. These cells are known to migrate along white matter tracts ... a physiologically relevant extracellular space within which glioblastoma cells can migrate and invade. Since our models are micron-scale, ...

Pages